Healthcare

Arcline Investment buys majority of Akron Biotechnology

Arcline Investment Management said Sept. 11 that it acquired a majority of Akron Biotechnology LLC. Financial terms weren’t announced. Akron Biotechnology supplies cGMP-compliant products and services for the production of advanced therapy medicinal products, including cell therapies, gene therapies and engineered tissues. BroadOak Capital Partners invested in Akron in 2017, PitchBook said.

Full In Partners to acquire stake in ServiceCore

Full In Partners has acquired to acquire a "significant" stake in ServiceCore, a provider of business management software for the liquid waste and roll-off rental industry. No financial terms were disclosed.

HighCape to sell Cheetah Medical to Baxter International

Baxter International has agreed to acquire Cheetah Medical from HighCape Capital LP for $190 million cash upfront. Cheetah Medical is a provider of non-invasive fluid management monitoring technologies.

CHC recaps Infusion Management

Cimarron Healthcare Capital has recapitalized Infusion Management. No financial terms were disclosed. Based in Thousand Oaks, California, Infusion Management is an infusion therapy MSO providing services to Infusion for Health, a provider of infusion treatment services to patients in the Los Angeles market.

Morgan Stanley Capital’s Pathway Vet Alliance considers strategic options

CHC recaps Infusion Management

Cimarron Healthcare Capital has recapitalized Infusion Management. No financial terms were disclosed. Based in Thousand Oaks, California, Infusion Management is an infusion therapy MSO providing services to Infusion for Health, a provider of infusion treatment services to patients in the Los Angeles market.

WCAS taps Taheri as operating partner for healthcare team

Welsh, Carson, Anderson & Stowe has named Dr. Paul Taheri as an operating partner on the healthcare team. Currently, Taheri is CEO of Yale Medicine and a deputy dean for clinical affairs at the Yale School of Medicine.

Windjammer buys Hilco Vision

Windjammer Capital Investors has acquired Plainville, Massachusetts-based Hilco Vision, a distributor of branded and consumable professional eyecare products and optical accessories. No financial terms were disclosed. UPDATE: Blue Point Capital Partners has exited Hilco Vision as a result of the acquisition.

Goldman Sachs Merchant Banking exits Credible Behavioral Health

Martis Capital has completed a minority recap of Credible Behavioral Health Inc. Financial terms weren’t announced. With the deal, Goldman Sachs Merchant Banking Division has exited its investment in Credible. Based in Rockville, Maryland, Credible provides software for behavioral healthcare providers.

H.I.G. Capital to buy BioVectra for $250 mln

Mallinckrodt said Sept. 10 that it agreed to sell BioVectra Inc to H.I.G. Capital for about $250 million. The fixed consideration of $175 million includes an upfront payment of $135 million and a long-term note for $40 million, and contingent payments of up to $75 million. BioVectra is a contract development and manufacturing organization.